Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared dasotraline 4mg and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachResearchers compared dasotraline and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachResearchers compared ENX-102 and placebo, tracking side effects to assess safety in people with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixA Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
Read the official source — NCT00309699Researchers compared Paliperidone ER, placebo and Quetiapine to find out how the approaches affected manic symptoms in people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosResearchers compared Intramuscular Levosulpiride and Intramuscular Haloperidol to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingA Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimResearchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 As Adjunctive Treatment for Major Depressive Disorder (MDD)
This study was withdrawn before enrollment.
Multiple locations, including MilanA Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder
Read the official source — NCT00391222A Randomized, Double Blind, Placebo and Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Risperidone Long-acting Injectable (LAI) for the Prevention of Mood Episodes in the Treatment of Subjects With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingResearchers compared SEP-363856 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared Quetiapine and risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ShanghaiThis study evaluated the safety and effectiveness of SPN-810 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.